Jiangsu Hengrui Medicine
600276.SS
#465
Rank
S$58.27 B
Marketcap
$9.14
Share price
-1.00%
Change (1 day)
1.28%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total debt

Total debt on the balance sheet as of September 2024 : S$16.5 Million

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total debt is S$16.5 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Jiangsu Hengrui Medicine - Total debt on balance sheet (from 2000 to 2024)

Total debt by year

Year Total debt Change
2022-12-31S$0.26 B721.84%
2021-12-31S$32.16 M
2015-12-31S$2.18 M2.58%
2014-12-31S$2.13 M-49.04%
2013-12-31S$4.18 M113.47%
2012-12-31S$1.96 M-52.41%
2011-12-31S$4.12 M5.78%
2010-12-31S$3.89 M89.56%
2009-12-31S$2.05 M
2007-12-31S$11.83 M25.54%
2006-12-31S$9.42 M-4.81%
2005-12-31S$9.9 M-49.3%
2004-12-31S$19.53 M-74.99%
2003-12-31S$78.11 M45.27%
2002-12-31S$53.77 M-4.56%
2001-12-31S$56.34 M47.29%
2000-12-31S$38.25 M-8.32%
1999-12-31S$41.72 M45.43%
1998-12-31S$28.69 M7.94%
1997-12-31S$26.58 M